Healthcare >> CEO Interviews >> February 19, 2001
DAVID W. MAZEPINK is the President and Chief Executive Officer of
HemoTherapies Inc. and is a member of the company's Board of Directors.
He has over 25 years experience in healthcare marketing, sales and
financial services. Mr. Mazepink has served in senior management
positions with G.E. Medical's Health Industry Marketing Group. He also
held management positions at Scientific Leasing Inc. where his primary
focus was to assist hospitals in the planning, development and financing
of high tech medical services. Mr. Mazepink was previously President of
Mazepink & Associates, LLC, a healthcare services company that developed
marketing and sales strategies and private label finance programs for
medical equipment manufacturers. n addition, Mr. Mazepink assisted
companies in developing and implementing financial, operations, sales &
marketing and service agreement structures. Mr. Mazepink worked with
HemoCleanse for two years as a marketing consultant charged with
determining the optimal means of bringing their liver assist technology
to the market. Profile
HemoTherapies, Inc.?
Mr. Mazepink: HemoTherapies has a technology platform we can use to
advance treatment options for a
